Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/91/8d/ec/918decb3-bc72-b73c-945a-83dcba50bf1d/mza_792284397039913865.jpg/600x600bb.jpg
Market Lens
Kavout
98 episodes
14 hours ago
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...
Show more...
Investing
Business
RSS
All content for Market Lens is the property of Kavout and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...
Show more...
Investing
Business
https://storage.buzzsprout.com/fvk75nn2oi7ojvkcmc7wpys3lwtg?.jpg
Inside the Lab Where Beam Therapeutics is Rewriting the Rules of Genetic Medicine
Market Lens
2 minutes
1 week ago
Inside the Lab Where Beam Therapeutics is Rewriting the Rules of Genetic Medicine
Send us a text This episode provides an extensive overview of Beam Therapeutics, a biotechnology company focused on developing genetic medicines using base editing technology. Base editing is highlighted as a precise gene-editing approach that chemically modifies a single DNA base without causing the double-stranded DNA breaks associated with traditional CRISPR/Cas9 methods, which is believed to offer superior safety. Several documents describe Beam's pipeline, including lead programs like BE...
Market Lens
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...